Should You Invest Extra in Clinique, Dermalogica, Colorescience, PHYTOMER, StriVectin-SD, and iS Clinical Products?
There’s no doubt about it: Clinique, Dermalogica, Colorescience, PHYTOMER, StriVectin-SD, and iS Clinical products tend to cost a little more than drugstore brands and discount brands. However, if you care about the appearance and health of your skin, there are many reasons why you might want to consider investing in these products:
1) Safer ingredients. Many low-cost skincare lines are made with low-cost ingredients. While some of these ingredients are safe and beneficial for your skin, some are not. There is a long list of “approved” ingredients which can cause blemishes and even allergic reactions in those with sensitive skins. In addition, some low-cost products are made with actively toxic ingredients and are eventually recalled. Clinique, Dermalogica, Colorescience, PHYTOMER, StriVectin-SD, and iS Clinical products, on the other hand, are made by skin care experts and are made with ingredients that actually promote the health of your skin. When you use these ingredients, you can worry less about unsafe substances.
2) Value. When you use Clinique, Dermalogica, Colorescience, PHYTOMER, StriVectin-SD, and iS Clinical products, you often need only a little amount, since these products are made to be truly effective. Therefore, the difference between these quality products and low-cost products may not be as great as you think, when you consider that a bottle of these quality brands takes you much further.
3) Results. The makers of Clinique, Dermalogica, Colorescience, PHYTOMER, StriVectin-SD, and iS Clinical products invest heavily in research and innovation to create products that really work. Customers often report better results and smoother, healthier skin with Clinique, Dermalogica, Colorescience, PHYTOMER, StriVectin-SD, and iS Clinical products than with discount brands.
Category: Skin Care
Subscribe
If you enjoyed this article, subscribe to receive more just like it.
Comments (0)
Trackback URL | Comments RSS Feed
There are no comments yet. Why not be the first to speak your mind.